Investor profile
Taiho Ventures has backed 5 European tech companies across 7 funding rounds between 2021 and 2026, joining rounds totalling €146M. Most active in Healthtech. Data as of 6 Aug 2026.
Also recorded as: Taiho Ventures LLC
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Storm Therapeutics | UK | 2 | €76M |
| Transition Bio | UK | 1 | €47M |
| cellvie | Switzerland | 2 | €9.4M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
| Theolytics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Storm Therapeutics | Series C | €48M | 2026-04 |
| Transition Bio | Series A | €47M | 2022-06 |
| Storm Therapeutics | Series B | €28M | 2022-12 |
| Anavo Therapeutics |
| 1 |
| €5.5M |
| Seed |
| €8.5M |
| 2023-05 |
| Theolytics | Series A | €5.5M | 2021-01 |
| cellvie | Other | €5.1M | 2023-02 |
| cellvie | Other | €4.3M | 2025-09 |
